drugset / Trial / NCT07523165

Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis

NCT07523165 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Lifei Qingchang Granules in the treatment of patients with stable bronchiectasis. This is a multicenter, randomized, double-blind, placebo-controlled clinical trial. Researchers plan to enroll a total of 150 adult participants (aged 18-75) who have been diagnosed with stable bronchiectasis and experience at least one acute exacerbation in the past 12 months. Participants will be randomly assigned into two groups in a 1:1 ratio: * The treatment group will receive Lifei Qingchang Granules along with standard postural drainage therapy. * The control group will receive a matching placebo along with standard postural drainage therapy. The treatment period will last for 3 months. The main goal is to see if the treatment can improve patients' respiratory symptoms and overall quality of life.

Timeline

Start
2026-04
Primary completion
2028-03
Completion
2028-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lifei Qingchang Granules Traditional medicine (herbal / TCM) 1 unknown Oral

Indications